Neuren Pharmaceuticals | NEU - Devedores Comerciais

Preço das Ações
12.27
Mudança Diária
0.34 2.85%
Mensal
5.50%
Anual
5.23%
Q2 Previsão
12.10




Devedores Comerciais Alterar Data
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Avita Medical AUD 9.11M 2.26M 2025-12
Clinuvel Pharmaceuticals AUD 16.58M 10.88M 2025-12
Dianthus Therapeutics USD 52K 4.95M 2025-12
Genetic Signatures AUD 6.49M 3.11M 2025-12
Ionis Pharmaceuticals USD 74M 8M 2026-03
Medical Developments International AUD 7.48M 174K 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organon & Co USD 1.48B 0 2025-09
Paradigm Biopharmaceuticals AUD 6.31M 58.85K 2025-12
PYC Therapeutics AUD 32.59M 8.52M 2025-12
Starpharma Holdings AUD 4.17M 52K 2025-12
Tectonic Therapeutic USD 0 270K 2023-12
Telix Pharmaceuticals AUD 135.24M 5.72M 2025-12
Viatris USD 3.03B 340.3M 2025-12
Xeris Pharmaceuticals USD 51.05M 2.7M 2025-12